Sethuraman Natarajan
SEC insider (Form 3/4/5 filer). CIK 0001873394. President, Research & Develop. at Entrada Therapeutics, Inc. (TRDA). 25 reported Form 4/5 transactions since Sep 2024; latest on Sep 2, 2026. Located in BOSTON, MA.
Companies Sethuraman Natarajan has filed insider reports for
- Entrada Therapeutics, Inc. (TRDA): Officer, President, Research & Develop.
Sethuraman Natarajan
CIK: 0001873394
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Entrada Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Sep 2, 2026TRDA
Entrada Therapeutics, Inc.
Tax PaymentDirect2.1K shares at avg. $7.14$15K - May 4, 2026TRDA
Entrada Therapeutics, Inc.
SaleDirect25.9K shares at avg. $15.39$399K - Mar 3, 2026TRDA
Entrada Therapeutics, Inc.
Tax PaymentDirect7.6K shares at avg. $11.76$89K - Mar 2, 2026TRDA
Entrada Therapeutics, Inc.
Tax PaymentDirect3.9K shares at avg. $11.66$45K - Mar 1, 2026TRDA
Entrada Therapeutics, Inc.
AwardDirect55.8K shares- - Sep 2, 2025TRDA
Entrada Therapeutics, Inc.
Tax PaymentDirect1.8K shares at avg. $5.43$10K - Mar 3, 2025TRDA
Entrada Therapeutics, Inc.
Tax PaymentDirect6.1K shares at avg. $11.68$72K - Mar 1, 2025TRDA
Entrada Therapeutics, Inc.
AwardDirect60.8K shares- - Dec 3, 2024TRDA
Entrada Therapeutics, Inc.
SaleDirect11.7K shares at avg. $20.15$236K - Dec 2, 2024TRDA
Entrada Therapeutics, Inc.
SaleDirect4.1K shares at avg. $20.26$83K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 2, 2026 | TRDA Entrada Therapeutics, Inc. | Tax Payment | 2,079 | $7.14 | $14,852 | Direct |
| May 4, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 25,907 | $15.39 | $398,810 | Direct |
| Mar 3, 2026 | TRDA Entrada Therapeutics, Inc. | Tax Payment | 7,577 | $11.76 | $89,078 | Direct |
| Mar 2, 2026 | TRDA Entrada Therapeutics, Inc. | Tax Payment | 3,898 | $11.66 | $45,442 | Direct |
| Mar 1, 2026 | TRDA Entrada Therapeutics, Inc. | Award | 55,800 | - | $0 | Direct |
| Sep 2, 2025 | TRDA Entrada Therapeutics, Inc. | Tax Payment | 1,760 | $5.43 | $9,557 | Direct |
| Mar 3, 2025 | TRDA Entrada Therapeutics, Inc. | Tax Payment | 6,138 | $11.68 | $71,683 | Direct |
| Mar 1, 2025 | TRDA Entrada Therapeutics, Inc. | Award | 60,800 | - | - | Direct |
| Dec 3, 2024 | TRDA Entrada Therapeutics, Inc. | Sale | 11,703 | $20.15 | $235,786 | Direct |
| Dec 2, 2024 | TRDA Entrada Therapeutics, Inc. | Sale | 4,088 | $20.26 | $82,834 | Direct |
1-10 of 25 transactions